共 50 条
- [41] Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid TumorsADVANCED SCIENCE, 2023, 10 (25)Matos, Ana I. I.Peres, CarinaCarreira, BarbaraMoura, Liane I. F.Acurcio, Rita C. C.Vogel, TheresaWegener, ErikRibeiro, FilipaAfonso, Marta B. B.Santos, Fabio M. F.Martinez-Barriocanal, AguedaArango, DiegoViana, Ana S. S.Gois, Pedro M. P.Silva, Liana C. C.Rodrigues, Cecilia M. P.Graca, LuisJordan, RainerSatchi-Fainaro, RonitFlorindo, Helena F. F.
- [42] Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIMEBIOMEDICINE, 2023, 96Placke, Jan-MalteKimmig, MonaGriewank, KlausHerbst, RudolfTerheyden, PatrickUtikal, JochenPfoehler, ClaudiaUlrich, JensKreuter, AlexanderMohr, PeterGutzmer, RalfMeier, FriedegundDippel, EdgarWelzel, JuliaEngel, Daniel RobertKreft, SophiaSucker, AntjeLodde, GeorgKrefting, FrederikStoffels, IngoKlode, JoachimRoesch, AlexanderZimmer, LisaLivingstone, ElisabethHadaschik, EvaBecker, Juergen C.Weichenthal, MichaelTasdogan, AlpaslanSchadendorf, DirkUgurel, Selma
- [43] Human gut microbial communities dictate efficacy of anti-PD-1 therapy in a humanized microbiome mouse model of gliomaNEURO-ONCOLOGY ADVANCES, 2021, 3 (01)Dees, Kory J.Koo, HyunminHumphreys, J. FraserHakim, Joseph A.Crossman, David K.Crowley, Michael R.Nabors, L. BurtonBenveniste, Etty N.Morrow, Casey D.McFarland, Braden C.
- [44] An engineered PD-1-based and MMP-2/9-oriented fusion protein exerts potent antitumor effects against melanomaBMB REPORTS, 2018, 51 (11) : 572 - 577Wei, MulanLiu, XujieCao, ChunyuYang, JianlinLv, YafengHuang, JiaojiaoWang, YanlinQin, Ye
- [45] Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical ChemistryCANCERS, 2021, 13 (23)Serna-Higuita, Lina MariaAmaral, TeresaForschner, AndreaLeiter, UlrikeFlatz, LukasSeeber, OliviaThomas, IoannisGarbe, ClausEigentler, Thomas KurtMartus, Peter
- [46] Long-Term Outcomes of dMMR/MSI-H Rectal Cancer Treated With Anti - PD-1-Based Immunotherapy as Curative-Intent TreatmentJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (03):Yu, Jie-HaiLiao, Le -EnXiao, Bin-YiZhang, XuanWu, Ai -WenCheng, YongTang, Jing-HuaJiang, WuKong, Ling-HengHan, KaiMei, Wei-JianHong, Zhi-GangYang, Wan -JunLi, Dan -DanPan, Zhi-ZhongLi, Yun-FengZhang, Xiao-ShiDing, Pei-Rong
- [47] Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancerBIOMARKER RESEARCH, 2024, 12 (01)Zhu, ChengpeiWang, YunchaoZhu, RuijuanWang, ShanshanXue, JingnanZhang, DongyaLan, ZhouZhang, ChenchenLiang, YajunZhang, NanXun, ZiyuZhang, LonghaoNing, CongYang, XuChao, JiashuoLong, JunyuYang, XiaoboWang, HanpingSang, XintingJiang, XianzhiZhao, Haitao
- [48] Biostimulating Gut Microbiome with Bilberry Anthocyanin Combo to Enhance Anti-PD-L1 Efficiency against Murine Colon CancerMICROORGANISMS, 2020, 8 (02)Liu, XuerunWang, LuoyangJing, NanJiang, GuoqiangLiu, Zheng
- [50] Response to anti-PD-1 based therapy in metastatic melanoma patients is associated with the diversity and composition of the gut microbiomeCANCER RESEARCH, 2017, 77Gopalakrishnan, VancheswaranSpencer, ChristineReuben, AlexandrePrieto, PeterVicente, DiegoKarpinets, Tatiana V.Hudgens, Courtney W.Hutchinson, Diane S.Tetzlaff, MichaelLazar, AlexanderDavies, Michael A.Gershenwald, Jeffrey E.Jenq, RobertHwu, PatrickSharma, PadmaneeAllison, JamesFutreal, AndrewAjami, NadimPetrosino, JosephDaniel-MacDougall, CarrieWargo, Jennifer A.